AI assistant
Biohit Oyj Board/Management Information 2019
3304_iss_2019-01-31_8db3cd8a-3aa7-41f2-8a44-21cf368c5195.html
Board/Management Information
Open in viewerOpens in your device viewer
Disclosure 367945
Biohit Oyj - Changes board/management/auditors
Business Development Director Lea Paloheimo will retire from Biohit Oyj
Biohit Oyj 31.01.2019 at 12:00 local time (EST)
Biohit’s management team member Business Development Director Lea Paloheimo will retire as planned 31st of January 2019. Lea Paloheimo has been employed by Biohit since 2001.
”I would like to thank Lea for the excellent work during these years at Biohit in multiple different roles”, says Semi Korpela, President and CEO of Biohit.
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
www.biohithealthcare.com
Biohit Oyj in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission ‘Innovating for Health’ means that we provide innovative products and services to promote research and early diagnostics. Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit’s B series shares (BIOBV) are quoted on NASDAQ OMX Helsinki under Small cap/Healthcare. www.biohithealthcare.com